A Selective C-Met and TRKS Inhibitor Indo5 Suppresses Hepatocellular Carcinoma Growth

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-019-1104-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Met Tyrosine Kinase Inhibitor, PF-2341066, Suppresses Growth and Invasion of Nasopharyngeal Carcinoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

C-Met: A Potential Therapeutic Target for Hepatocellular Carcinoma

Drug discoveries & therapeutics
MedicineToxicologyPharmaceuticsPharmacology
2011English

Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2013English

Significance of PD‑L1 Clones and C‑MET Expression in Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2019English

Prognostic Value of C-Met Overexpression in Hepatocellular Carcinoma: A Meta-Analysis and Review

Oncotarget
Oncology
2017English

Targeting Pin1 by Inhibitor API-1 Regulates microRNA Biogenesis and Suppresses Hepatocellular Carcinoma Development

Hepatology
MedicineHepatology
2018English

Butein Suppresses Hepatocellular Carcinoma Growth via Modulating Aurora B Kinase Activity

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2018English

FXR Induces SOCS3 and Suppresses Hepatocellular Carcinoma

Oncotarget
Oncology
2015English

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy